&w=3840&q=100)
‘Now I'm the hunter': Cornered, Trump claims turning table on critics, rivals amid Epstein files row
The White House on Tuesday shared a post on X that gallantly showed President Donald Trump, with the caption, 'I was the hunted, now I am the hunter,' a quote said by the Republican leader referring to Democrat leaders.
The post read, 'They came after the wrong man.'
They came after the wrong man. pic.twitter.com/hgKfdvAVQS — The White House (@WhiteHouse) July 22, 2025
STORY CONTINUES BELOW THIS AD
Trump completed six months in the White House on Monday. These six months were defined by chaos, internal struggles, and rifts with the world that cornered Trump. The president has come under attack from not only the Opposition but within his Maga (Make America Great Again) campaign members.
😳Trump: "I was the hunted, now I'm the hunter"
The golden collection of quotes from the U.S. president got a new addition. https://t.co/YrF6Ovznuv pic.twitter.com/fH7Gs5mdsk — NEXTA (@nexta_tv) June 19, 2025
How the tables turn
The US President has long been accused of capitalising on Russia in his favour to win the 2016 elections. However, on Monday, Trump turned that accusation around on former President Barack Obama.
The Office of the Director of National Intelligence (ODNI) under Tulsi Gabbard has published a report 'revealing overwhelming evidence' that President Obama and his national security officials 'manufactured and politicised intelligence' to launch a 'years-long coup against President Trump.'
The declassified files show Obama administration officials exchanging correspondence regarding Russian attempts to interfere in the election, concluding that while it was unlikely Russian hackers could successfully breach physical election infrastructure or alter vote totals without being detected, they could potentially succeed in undermining public confidence in the electoral process.
Trump posts AI video
Escalating his attacks against Obama, Trump posted an AI-generated video showing the former president getting arrested by FBI agents in the Oval Office, the same room he once occupied.
The digitally altered video, shared on Trump's Truth Social platform, opens with Obama saying, 'especially the President is above the law,' followed by a montage of various US leaders asserting, 'no one is above the law.' The scene then shifts to a fabricated sequence of two FBI agents handcuffing Obama, while Trump watches from the sidelines with a smile. The clip ends with a fake shot of Obama in an orange jumpsuit behind bars.
STORY CONTINUES BELOW THIS AD

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)

Business Standard
25 minutes ago
- Business Standard
Donald Trump's tax law to add $3.4 trillion to US deficits, says CBO
President Donald Trump's recently enacted tax and spending law will add $3.4 trillion to US deficits over a decade and leave millions without health care coverage, according to a new estimate from the nonpartisan Congressional Budget Office. The CBO score for the law, released Monday, reflects a $4.5 trillion decrease in revenues and a $1.1 trillion decline in spending through 2034, relative to a current-law baseline. The new analysis doesn't incorporate so-called dynamic effects, such as the impact on growth or interest rates over time that the legislation's measures might have. Trump signed the 'One Big Beautiful Bill' into law on July 4 after months of negotiations with congressional Republicans. Encompassing much of Trump's economic agenda, it permanently extends his 2017 income-tax cuts and some breaks for businesses, lifts the cap on federal deductions for state and local taxes and eliminates taxes on tips and overtime on a temporary basis, among other provisions. Passage of the law triggered warnings from some economists and investors about a widening of America's budget shortfall — already large by historical standards — that could push borrowing costs and inflation up. The Trump administration points to record collections from the tariffs he's imposed on most US imports this year, saying that revenue will help fill the gap. A number of spending cuts were included in the tax law in an effort to reduce deficits and offset the cost, including to Medicaid, which provides health insurance for low-income people. New work requirements for recipients of Medicaid under the age of 65, are set to begin by the end of 2026. The law also limits states' ability to tax health care providers to help fund the program. Provisions in the law will result in 10 million Americans losing health insurance by 2034, according to the CBO analysis. The potential loss of health insurance coverage comes as rising prices due to tariffs already threaten to create increased economic hardship for low-income families. June inflation data showed some signs of the levies' impact on costs and economists expect prices to continue to rise over the summer. This would disproportionately impact low-income Americans as they tend to spend a larger share of their income on necessities, such as food. At the request of Senate Republicans, the bill was also scored separately relative to a current policy baseline. On that basis it would reduce deficits by $366 billion over a decade, with revenues falling $849 billion in the period — about one-fifth of the drop recorded in the conventional scoring. Lawmakers used this accounting maneuver to count the permanent extension of the 2017 income-tax cuts as costing nothing.
&w=3840&q=100)

Business Standard
25 minutes ago
- Business Standard
AstraZeneca unveils $50 bn US investment as pharma tariff threat looms
AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on Monday, the latest big investment by a pharmaceutical company reacting to President Donald Trump's tariff policy. The investment will fund a new drug manufacturing facility in Virginia and expand research and development (R&D) and cell therapy manufacturing in Maryland, Massachusetts, California, Indiana and Texas, it said in a statement. It will also upgrade the Anglo-Swedish drugmaker's U.S. clinical trial supply network and support ongoing investment in novel medicines. On Monday, AstraZeneca said the expansion supports its ambition to reach $80 billion in annual revenue by 2030, with half coming from the U.S. The U.S. accounted for more than 40% of AstraZeneca's annual revenue in 2024, and the company had been prioritising the market - the world's largest, worth $635 billion - before Trump's return to office. The move to scale up its U.S. footprint is the latest by a drugmaker as Trump threatens to impose import tariffs on the industry and seeks to boost domestic manufacturing. The sector has historically been spared from trade disputes. Trump has called on pharma companies to make more of the medicines they sell in the U.S. within the country, rather than importing active ingredients or finished medicines. He is also pushing for prices in the U.S. to fall to what other countries pay. CEO Pascal Soriot announced the plans in Washington, saying he believes that drug prices need to rise elsewhere and "equalize" with other countries effectively contributing more to research and development costs. "The United States cannot build or carry the cost of R&D for the entire world," he said. U.S. Commerce Secretary Howard Lutnick's department is leading a probe into pharmaceutical imports that could pave the way for new tariffs. "For decades Americans have been reliant on foreign supply of key pharmaceutical products. President Trump and our nation's new tariff policies are focused on ending this structural weakness," said Lutnick in a statement issued by AstraZeneca. While Trump has repeatedly threatened tariffs on the sector, he signalled earlier this month that companies would be given a year to 18 months to "get their act together" before any levies take effect. The company said that the timing and location of the announcement was linked to the U.S. policy environment, though some of the spending would have occurred regardless so that the infrastructure for future medicines was in place. The pledge is in addition to the $3.5 billion in investments the company announced in November 2024, the statement said. PLEDGES The $50 billion pledge matches the commitment announced by Swiss rival Roche in April and follows new spending plans unveiled this year by Eli Lilly & Co, Johnson & Johnson , Novartis, and Sanofi. Also present at the announcement was Virginia State Governor Glenn Youngkin, a vocal Trump ally who has defended the administration's tariff policies. The new Virginia facility - the company's largest single manufacturing investment - will produce active ingredients for AstraZeneca's experimental weight-loss medicines, including its oral GLP-1 candidate and an oral PCSK9 inhibitor for cholesterol management, it said. The company said the investment could create tens of thousands of new jobs, but declined to give specifics. It employs about 18,000 people in the U.S. and has a global workforce of about 90,000. In January it scrapped plans to invest 450 million pounds ($607.1 million) in its vaccine manufacturing plant in northern England, citing a cut in government support. Earlier this month, The Times reported the company was considering moving its stock market listing from London, where it is the exchange's most valuable company worth 159 billion pounds, to the U.S. The company declined to comment.


NDTV
25 minutes ago
- NDTV
"Dreamt Of Being James Bond": UK Man Guilty Of Trying To Spy For Russia
London: A British man who dreamed of being like James Bond was convicted on Tuesday of attempting to spy for Russia. Howard Phillips, 65, sought to pass information about former Defense Secretary Grant Shapps to two men he believed were Russian agents. However, the agents were undercover British intelligence agents. A jury at Winchester Crown Court found Phillips guilty of assisting what he believed to be a foreign intelligence agency. The unanimous verdict came after four hours of deliberations. He was remanded into custody and will be sentenced in the fall. No precise date was set. Prosecutors said Phillips offered to turn over Shapps' contact details as well as the location where he kept his private plane to "facilitate the Russians in listening on British defense plans." The defendant's ex-wife told the court that Phillips "would dream about being like James Bond," and watched films about the British secret services because he was "infatuated with it." Bethan David, head of the Crown Prosecution Service's counterterrorism division, said the conviction sends a clear message to anyone considering spying for Russia. "Phillips was brazen in his pursuit for financial gain, and unbothered about the potential detriment to his own country," David said.